Sam's News — health — 2026-08-26¶
Health¶
8.5 FDA approves first genetic therapy for advanced pancreatic cancer¶
The FDA approved daraxonrasib (Rasonque), developed by Revolution Medicines, on August 26, 2026, as the first genetic therapy targeting an underlying genetic cause of advanced pancreatic cancer. In clinical trials, the drug nearly doubled median overall survival to 13.2 months versus 6.7 months with standard chemotherapy as a second-line treatment.
- First genetic therapy targeting genetic cause of advanced pancreatic cancer
- Median overall survival: 13.2 months (Rasonque) vs. 6.7 months (chemotherapy)
- Second-line treatment in clinical trial
- FDA approval August 26, 2026
Sources: STAT News AI Web Searched
7.5 Scientists identify protein C3 as shortcut to calorie restriction's anti-aging benefits¶
Yale researchers identified complement protein C3 as a driver of age-related inflammation, finding that blocking it in mice reduced inflammation. A study of 42 CALERIE trial participants showed moderate calorie restriction (11–14% reduction) significantly lowered C3 levels, suggesting C3 targeting could replicate some anti-aging benefits without severe dietary restriction.
- C3 is an immune protein driving age-related chronic inflammation
- Moderate calorie restriction (11–14% over 2 years) significantly lowered C3
- White adipose tissue is primary source of C3 production affected by diet
- Blocking C3 in mice reduced age-related inflammation
- Research remains early stage; animal studies confirm mechanism
Sources: ScienceDaily / Yale School of Medicine AI Web Searched, ScienceDaily RSS, ScienceDaily — Health RSS, ScienceDaily — Nutrition RSS
7.5 Early childhood sugar exposure linked to cancer risk and aging 70 years later¶
A study of over 64,000 Britons used postwar sugar rationing as a natural experiment to show that reduced sugar exposure during the first 1,000 days of life correlates with lower cancer rates and slower biological aging decades later. Liver cancer rates were approximately 69% lower, and breast cancer 36% lower in those with longer rationing exposure.
- Study tracked 64,000+ people born 1951–1956 using sugar rationing as natural experiment
- Liver cancer approximately 69% lower with extended early-life rationing
- Breast cancer 36% lower with extended early-life rationing
- Extended rationing also linked to longer telomeres, indicating slower biological aging
- People with longer rationing maintained healthier diets into adulthood around age 50
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS, ScienceDaily — Nutrition RSS
7.5 Childhood trauma leaves epigenetic marks in brain cells that increase stress sensitivity¶
Researchers at Washington University and Princeton University identified an epigenetic mechanism by which early-life stress alters brain stress response through elevated SETD7 enzyme in dopamine neurons, loosening DNA packaging around stress-related genes. The team blocked this effect in mice, preventing heightened anxiety in adulthood.
- Early-life stress elevates SETD7 enzyme in ventral tegmental area dopamine neurons
- SETD7 loosens DNA packaging, making stress-related genes more accessible
- Epigenetic change primes brain to overreact to future stressors
- Researchers blocked effect in mice, preventing heightened adult anxiety
- Over half of children worldwide experience early-life stress
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
7 RFK Jr. Spreads Vaccine Misinformation as Measles Deaths Climb¶
Robert F. Kennedy Jr., health secretary in the Trump administration, faced backlash from Pennsylvania Governor Josh Shapiro for spreading vaccine misinformation as two measles-related deaths occurred among unvaccinated people. Kennedy denied spreading misinformation and blamed the Biden administration for declining vaccination rates, though he later urged measles vaccination at a public event.
- Two measles-related deaths among unvaccinated people in Pennsylvania
- Kennedy cast doubt on MMR vaccine safety and efficacy
- Kennedy blamed Biden administration for declining pediatric vaccination rates
- Shapiro stated Kennedy's rhetoric and misinformation negatively impacted communities
Sources: STAT News AI Web Searched
7 Revolution Oncology Wins FDA Expedited Approval for Pancreatic Cancer Drug¶
Revolution Oncology's new pancreatic cancer drug has received speedy FDA approval.
Sources: Reuters RSS
6.5 Genetic predisposition determines low-carb diet's effect on LDL cholesterol¶
People with genetic susceptibility to high cholesterol experience sharper LDL spikes on low-carb diets high in saturated fat, explaining variable dietary outcomes.
Sources: ScienceDaily RSS, ScienceDaily — Health RSS, ScienceDaily — Nutrition RSS
6.5 New class of cardiovascular drugs shows promising clinical data¶
Key trial data for a new class of cardio drugs is approaching, alongside announcements on GSK's shingles vaccine and investment in women's health.
Sources: STAT News RSS
Public Health¶
7.5 Shingles Vaccine Linked to Reduced Heart Disease Risk in 'Natural Experiment'¶
Oxford researchers found that people aged 60+ who received Shingrix (newer recombinant shingles vaccine) versus Zostavax showed 9% lower cardiovascular burden over seven years in a natural experiment using electronic health records. This follows the team's 2024 finding linking Shingrix to lower dementia risk.
- 9% lower cardiovascular burden over seven years
- 72,000 vaccinated people aged 60+
- Composite measure: coronary heart disease, heart attacks, strokes, heart failure
- Shingrix approved October 2017, replacing Zostavax
- Earlier 2024 study linked vaccine to lower dementia risk
Sources: STAT AI Web Searched, STAT News RSS
Pharma¶
7 New Lp(a)-Lowering Treatments Near Market as Cardiovascular Risk Factor Therapy Expands¶
Pharmaceutical companies are advancing treatments targeting lipoprotein(a), a genetic cardiovascular risk factor affecting approximately 1 in 5 people with no approved therapy. Novartis leads development, with multiple candidates in late-stage trials and billions in market revenue potential expected near-term.
- Lp(a) affects approximately 1 in 5 people
- Genetic risk factor; cannot be addressed by lifestyle changes alone
- Currently no approved therapy to lower Lp(a) levels
- Represents billions in potential revenue
- Treatments expected near-term market entry
Sources: STAT News AI Web Searched